𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Community-acquired pneumonia: A practical approach to management for the hospitalist

✍ Scribed by Bradley A. Sharpe; Scott A. Flanders


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
246 KB
Volume
1
Category
Article
ISSN
1553-5592

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Community‐acquired pneumonia (CAP) is common, and inpatient physicians should be familiar with the most current evidence about and guidelines for CAP management. Our conclusions and recommendations include: Streptococcus pneumoniae is the most common identified cause of CAP requiring hospitalization, whereas Legionella pneumophila is a common cause of severe CAP. The chest radiograph remains an essential initial test in the diagnosis of CAP and should be supplemented by blood cultures sampled prior to antibiotic therapy and sputum for gram stain and culture if a high‐quality specimen can be rapidly processed. Once the diagnosis is made, the Pneumonia Severity Index (PSI) should be used to optimize the location of treatment and to provide prognostic information. Absent other mitigating factors, patients in PSI risk classes I, II, and III can safely be treated as outpatients. Hospitalized patients with CAP should be treated promptly with empiric antibiotics. Nonsevere pneumonia should be treated with a parenteral β‐lactam plus either doxycycline or a macrolide. Patients admitted to the intensive care unit should be treated with a β‐lactam plus either a macrolide or a fluoroquinolone as well as be evaluated for pseudomonal risk factors. Most patients with nonsevere CAP reach clinical stability in 2–3 days and should be considered for a switch to oral therapy and discharge shortly thereafter. Patients should receive pneumococcal vaccination, influenza vaccination, and tobacco cessation counseling prior to discharge if eligible. Multiple quality indicators are measured and publicly reported in the management of CAP, which provides hospitals with an opportunity to improve care processes and patient outcomes. Journal of Hospital Medicine 2006;1:177–190. Β© 2006 Society of Hospital Medicine.


πŸ“œ SIMILAR VOLUMES


Peripheral neuropathies: A practical app
✍ Rachel Thompson; Michael D. Weiss πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

## Abstract Peripheral neuropathies are a common problem with a myriad of potential etiologies that may be encountered acutely. Early diagnosis of certain neuropathies can lead to life‐saving therapy. This article reviews the literature on diagnostic approaches to peripheral neuropathies and sugges

Breaking bad news: A practical approach
✍ Tracy A. Minichiello; David Ling; Debra K. Ucci πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

## Abstract Communicating bad news to patients and their families is a difficult but routine responsibility for hospitalists. Most practitioners have little or no formal training for this task. Preparation for, delivery of, and follow‐up to these conversations should be deliberately planned in orde

Periprocedural antithrombotic management
✍ Russell Vinik; Nathan Wanner; Robert C. Pendleton πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

Many patients who are on long-term antithrombotic therapy (e.g. warfarin and/or antiplatelet agents) must be assessed for temporary discontinuation for a procedure or surgery, making this a salient topic for the hospitalist physician. Discontinuation of antithromhotic therapy can place patients at i

A practical approach to the use of nanop
✍ Janet Wendorf; Manmohan Singh; James Chesko; Jina Kazzaz; Elawati Soewanan; Mild πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 186 KB

The objective of this work was to obtain a nanoparticle formulation that could be sterile filtered, lyophilized, and resuspended to the initial size with excipients appropriate for use as a vaccine formulation. Poly(lactide-co-glycolide) (PLG) polymers were used to create nanoparticles ranging in si